Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May-Jun;10(3):263-265.
doi: 10.1016/j.jceh.2020.03.001. Epub 2020 Apr 1.

Gastrointestinal and Liver Manifestations of COVID-19

Affiliations
Review

Gastrointestinal and Liver Manifestations of COVID-19

Amol Agarwal et al. J Clin Exp Hepatol. 2020 May-Jun.

Abstract

The worldwide pandemic of COVID-19, caused by the virus SARS-CoV,-2 has continued to progress, and increasing information is becoming available about the incidence of digestive symptoms as well as abnormal liver-associated enzymes in patients who are infected. These are postulated to be related to the virus's use of ACE-2 receptors located on certain intestinal cells, cholangiocytes, and hepatocytes. This brief review summarizes the available limited data on digestive manifestations of COVID-19. A significant proportion of COVID-19 patients can present initially with only digestive complaints. The most common digestive symptoms are anorexia, nausea, vomiting, and diarrhea. Liver-related transaminases are elevated in a substantial proportion of patients, although generally only mildly elevated. Currently there is no firm evidence to suggest that severity of digestive symptoms corresponds to severity of COVID-19 clinical course, however, more severe alterations in liver enzymes may correlate with worse clinical course. Given use of antiviral and antibacterial agents in sicker patients, drug-induced liver injury cannot be ruled out either in these cases. Although viral RNA can be detected in stool, it is unclear whether fecal-oral transmission can be achieved by the virus. As further data becomes available, our understanding of the digestive manifestations of COVID-19 will continue to evolve.

PubMed Disclaimer

References

    1. Wu F., Zhao S., Yu B. A new coronavirus associated with human disease in China. Nature. 2020 Mar;579:265–269. - PMC - PubMed
    1. Yeo C., Kaushal S., Yeo D. Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol Hepatol. 2020 doi: 10.1016/S2468-1253(20)30048-0. published online Feb 19. - DOI - PMC - PubMed
    1. Chen Y., Guo Y., Pan Y., Zhao Z.H. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun. 2020 doi: 10.1016/j.bbrc.2020.02.071. - DOI - PMC - PubMed
    1. Liang W., Feng Z., Rao S. Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut. 2020 Feb 26 doi: 10.1136/gutjnl-2020-320832. pii: gutjnl-2020-320832. [Epub ahead of print] - DOI - PubMed
    1. Ong J., Young B.E., Ong S.L. COVID-19 in gastroenterology: a clinical perspective. Gut. 2020;0:1–2. doi: 10.1136/gutjnl-2020-321051. [Epub ahead of print] - DOI - PubMed